Slideshow
Author(s):
Highlights include how cost-effective insulin reduces hospital visits; prevalence of restrictive lung disease in T2DM patients; and the wonders of self-monitoring for cost of care.
CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes
Medical Ethics Unpacked: GLP-1 Allocation and Challenges of Equitable Access
Monlunabant Misses Primary Endpoint in Phase 2 Diabetic Kidney Disease Trial
Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D
Endocrinology Month in Review: January 2025
Tirzepatide Could Replace Daily Hormone Shots for Rare Genetic Fat Disorder